Physician profile
Jason Daily
NPI 1043290836
$35,087.65
in general payments reported to CMS, 2019-2025
48 companies · $2,696 in 2025
The $2,696 reported for 2025 was more than what 81% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $472 · 2021: $1,951 · 2022: $1,946 · 2023: $2,058 · 2024: $1,464 · 2025: $2,696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,135 · Education: $83.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,135.39 |
| Education | $83.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $26,162.69 | 2019-2025 | Evenity, Prolia, Repatha |
| Novo Nordisk INC | $860.19 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $795.74 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Sanofi-Aventis U.S. LLC | $741.11 | 2019-2025 | |
| Medtronic, INC. | $729.01 | 2021-2025 | Minimed 780g |
| Insulet Corporation | $705.61 | 2021-2025 | Omnipod |
| Dexcom, INC. | $671.33 | 2019-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Abbott Laboratories | $577.13 | 2019-2025 | Freestyle Libre, Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $437.11 | 2019-2025 | Jardiance, Synjardy, Ofev |
| Xeris Pharmaceuticals, INC. | $435.02 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Beta Bionics, INC. | $304.41 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Medtronic Minimed, INC. | $275.48 | 2019-2020 | |
| Abbvie INC. | $237.65 | 2020-2025 | Synthroid |
| Ucb, INC. | $163.93 | 2024-2025 | Bimzelx, Cimzia |
| Radius Health, INC. | $131.39 | 2019-2021 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Daily listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.